Exploring variations in recommended first‐choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity

Abstract

AbstractIntroductionThere are known disparities in the treatment of infectious diseases. However, disparities in treatment of complicated urinary tract infections (UTIs) are largely uninvestigated.ObjectivesWe characterized UTI treatment among males in Veterans Affairs (VA) outpatient settings by age, race, and ethnicity and identified demographic characteristics predictive of recommended first‐choice antibiotic therapy.MethodsWe conducted a national, retrospective cohort study of male VA patients diagnosed with a UTI and dispensed an outpatient antibiotic from January 2010 through December 2020. Recommended first‐choice therapy for complicated UTI was defined as use of a recommended first‐line antibiotic drug choice regardless of area of involvement (ciprofloxacin, levofloxacin, or sulfamethoxazole/trimethoprim) and a recommended duration of 7 to 10 days of therapy. Multivariable models were used to identify demographic predictors of recommended first‐choice therapy (adjusted odds ratio [aOR] > 1).ResultsWe identified a total of 157,898 males diagnosed and treated for a UTI in the outpatient setting. The average antibiotic duration was 9.4 days (±standard deviation [SD] 4.6), and 47.6% of patients were treated with ciprofloxacin, 25.1% with sulfamethoxazole/trimethoprim, 7.6% with nitrofurantoin, and 6.6% with levofloxacin. Only half of the male patients (50.6%, n = 79,928) were treated with recommended first‐choice therapy (first‐line drug choice and appropriate duration); 77.6% (n = 122,590) were treated with a recommended antibiotic choice and 65.9% (n = 104,070) with a recommended duration. Age 18–49 years (aOR 1.07, 95% confidence interval [CI] 1.03–1.11) versus age ≥65 years was the only demographic factor predictive of recommended first‐choice therapy.ConclusionsNearly half of the patients included in this study did not receive recommended first‐choice therapies; however, racial and ethnic disparities were not identified. Underutilization of recommended first‐choice antibiotic therapy in complicated UTIs continues to be an area of focus for antimicrobial stewardship programs.